Synchron Unveils Chiral™: The World’s First Cognitive AI Brain Model Introduction to Chiral™ and Cognitive AI Synchron, a pioneering brain-computer interface (BCI) company, has unveiled Chiral™, the world’s first cognitive AI brain foundation model. This groundbreaking development marks the beginning…
Precision BioSciences Presents Promising Preclinical Data for PBGENE-DMD in Duchenne Muscular Dystrophy at 2025 MDA Conference Introduction to PBGENE-DMD and the DMD Challenge Precision BioSciences, Inc., a clinical-stage gene editing company, has announced the presentation of promising preclinical data for…
Cellares and Cabaletta Bio Successfully Complete Technology Adoption Program for Rese-cel Using Cell Shuttle™ Platform Cellares, the first Integrated Development and Manufacturing Organization (IDMO), has successfully concluded the Technology Adoption Program (TAP) for its innovative automated cell therapy manufacturing platform,…
Sapio Sciences Integrates NVIDIA BioNeMo to Streamline AI-Driven Drug Discovery Sapio Sciences, the science-aware™ lab informatics platform, has announced a significant advancement in the field of drug discovery with the integration of NVIDIA BioNeMo into its platform. This integration seamlessly…
PHC and Cyfuse Develop Breakthrough Technology for Commercializing 3D Cell Products PHC Corporation, a subsidiary of PHC Holdings Corporation, and Cyfuse Biomedical K.K. have announced a significant milestone in the field of regenerative and cell therapy. The two companies have…
Industry 4.0 Gains Traction Across Europe’s Manufacturing Sector The digital transformation of Europe’s manufacturing industry continues to accelerate, with Industry 4.0 initiatives making significant strides. A new research report by Information Services Group (ISG), a leading global technology research and…
GeneDx Showcases Groundbreaking Genomic Research at 2025 ACMG Annual Clinical Genetics Meeting GeneDx, a leader in improving health outcomes through genomic insights, is making significant contributions to the field of genetics at the 2025 American College of Medical Genetics and…
Vir Biotechnology Launches Phase 3 ECLIPSE Program for Chronic Hepatitis Delta Treatment Vir Biotechnology, Inc. has officially enrolled its first patient in the Phase 3 ECLIPSE registrational program, a significant step in evaluating the efficacy and safety of the combination…
SOTIO Expands ADC Pipeline with Bispecific Candidates SOT112 and SOT113 SOTIO Biotech Advances Two Promising Bispecific Antibody-Drug Conjugate Programs SOTIO Biotech, a clinical-stage biopharmaceutical company owned by PPF Group, has announced an exciting development in its collaboration with Synaffix B.V.,…
Onego Bio Selects Jefferson County for Flagship Egg Protein Manufacturing Facility Onego Bio, a leading food ingredient company specializing in egg protein powder through fermentation, has chosen Jefferson County, Wisconsin, as the location for its flagship manufacturing facility. The company’s…
Baszucki Group Launches Two Initiatives Exploring Ketogenic Therapy for Youth with Bipolar Disorder Baszucki Group has announced the launch of two innovative research initiatives aimed at exploring the effectiveness of ketogenic therapy for children and adolescents with bipolar disorder. These…
Ensitrelvir Demonstrates Effectiveness in Preventing COVID-19 as Post-Exposure Prophylaxis: Results from the SCORPIO-PEP Phase 3 Trial SCORPIO-PEP Phase 3: Ensitrelvir First Oral Antiviral to Prevent COVID-19 as Post-Exposure Prophylaxis At the Conference on Retroviruses and Opportunistic Infections 2025, Shionogi &…